We next selected a reduced panel of patient-derived cell lines with high (M285, M249, M230, and M207), intermediate (M229 and M202), and negative (A549, a lung adenocarcinoma cell line) expression of TYRP1 measured by RNAseq and quantified the intracellular and surface expression TYRP1 by flow cytometry. This evidence concerns the gene TYRP1 and lung adenocarcinoma.